Legal & General Group Plc - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 129 filers reported holding AMNEAL PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 2.87 and the average weighting 0.1%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$908,631
+29.9%
143,085
+24.0%
0.00%
Q1 2024$699,475
+33.3%
115,425
+33.6%
0.00%
Q4 2023$524,606
+1106.7%
86,426
+738.9%
0.00%
Q3 2023$43,474
+20.8%
10,302
-11.1%
0.00%
Q2 2023$35,984
+23.3%
11,589
-44.8%
0.00%
Q1 2023$29,180
-66.3%
20,993
-51.8%
0.00%
Q4 2022$86,595
+6.9%
43,515
+8.9%
0.00%
Q3 2022$81,000
-33.6%
39,958
+4.0%
0.00%
Q2 2022$122,000
-25.2%
38,430
-1.5%
0.00%
Q1 2022$163,000
-66.5%
39,021
-61.6%
0.00%
Q4 2021$487,000
-10.3%
101,6330.0%0.00%
Q3 2021$543,000
+27.8%
101,633
+22.5%
0.00%
Q2 2021$425,000
-24.0%
82,9390.0%0.00%
Q1 2021$559,000
+48.3%
82,939
+0.4%
0.00%
Q4 2020$377,000
+17.1%
82,574
-0.3%
0.00%
Q3 2020$322,000
-22.4%
82,790
-5.0%
0.00%
Q2 2020$415,000
+33.9%
87,139
-2.4%
0.00%
Q1 2020$310,000
+26.5%
89,320
+75.5%
0.00%
Q4 2019$245,000
+100.8%
50,894
+20.7%
0.00%
Q3 2019$122,000
-54.8%
42,155
+11.8%
0.00%
Q2 2019$270,000
-45.5%
37,707
+8.1%
0.00%
Q1 2019$495,000
+6.0%
34,891
+1.1%
0.00%
Q4 2018$467,000
-35.7%
34,505
+5.5%
0.00%
-100.0%
Q3 2018$726,000
+63.1%
32,695
+20.7%
0.00%
Q2 2018$445,00027,0990.00%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Fosun International Ltd 4,655,403$29,561,8099.98%
TPG GP A, LLC 12,328,767$78,287,6701.80%
Rubric Capital Management LP 10,721,778$68,083,2901.78%
TUCKER ASSET MANAGEMENT LLC 1,111,064$7,055,2561.54%
BlackBarn Capital Partners LP 2,000,000$12,700,0001.13%
Nantahala Capital Management 2,669,943$16,954,1381.00%
SANDERS MORRIS HARRIS LLC 567,196$3,601,6950.59%
Jackson Creek Investment Advisors LLC 161,760$1,0270.38%
HENNESSY ADVISORS INC 1,388,600$8,817,6100.33%
Signature Wealth Management Partners, LLC 66,666$423,3290.32%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders